Puberty Blockers: NHS England Halts Routine Prescription
Puberty Blockers:Part-II
Landmark Decision:
NHS England ceases routine puberty blocker prescriptions.
Safety Concerns:
Lack of evidence prompts halt to routine prescriptions.
Limited Availability:
Puberty blockers now restricted to research trials.
Review Findings:
Interim report identifies gaps in evidence and care model.
Rising Referrals:
Sharp increase in referrals prompts scrutiny of gender services.
Continued Treatment:
Fewer than 100 youths currently on NHS puberty blockers.
Public Consultation:
Over 4,000 responses shape policy on gender services.
Safety Priority:
Decision prioritizes children's safety and wellbeing.
Polarized Debate:
Consultation reveals differing views on accessibility.
Future Studies:
NHS England plans study on puberty blockers by December 2024.
This is Part-II
For Puberty blocker
Part-I
Click below
Dot